# High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

> **NCT06003244** · NA · UNKNOWN · sponsor: **University of Zurich** · enrollment: 24 (estimated)

## Conditions studied

- Pulmonary Vascular Disease
- Pulmonary Artery Hypertension
- Chronic Thromboembolic Pulmonary Hypertension

## Interventions

- **OTHER:** 6-minute walk distance (6MWD) test
- **OTHER:** 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)

## Key facts

- **NCT ID:** NCT06003244
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-23
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06003244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06003244, "High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06003244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*